Medicated Skin Care in Kenya

September 2012 | 24 pages | ID: M2F0F11B62BEN
Euromonitor International Ltd

Abstracts

Self-medication is a common practice for Kenyan consumers as it is viewed as a cheap and quick way to deal with minor ailments, such as skin diseases for instance. Consumers are willing to use medicated skin care products to self-medicate especially if it is to be used for a mild skin rash, such as dermatophytosis. Consumers are also likely to self-medicate when they suffer from acne. This ailment is very common, especially amongst teenagers and young consumers. Most opt for products in cream...

Euromonitor International's Medicated Skin Care in Kenya report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Medicated Skin Care market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

MEDICATED SKIN CARE IN KENYA

Euromonitor International
September 2012

LIST OF CONTENTS AND TABLES

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
  Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  Table 3 Medicated Skin Care Company Shares by Value 2007-2011
  Table 4 Medicated Skin Care Brand Shares 2008-2011
  Table 5 Hair Loss Treatments Brand Shares 2008-2011
  Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Biodeal Laboratories Ltd in Consumer Health (kenya)
Strategic Direction
Key Facts
  Summary 1 Biodeal Laboratories Ltd: Key Facts
Company Background
Production
Competitive Positioning
  Summary 2 Biodeal Laboratories Ltd: Competitive Position 2011
Cosmos Ltd in Consumer Health (kenya)
Strategic Direction
Key Facts
  Summary 3 Cosmos Ltd: Key Facts
Company Background
Production
Competitive Positioning
  Summary 4 Cosmos Ltd: Competitive Position 2011
Executive Summary
Weakening Shilling Threatens To Slow Down Economic Growth
Self-medicating Gaining Popularity Amongst More Highly Informed Public
GlaxoSmithKline Continues To Lead
Rise of the Middle Class in the Wake of Global Recession
High Fuel and Production Costs Threaten To Curtail Value Sales Growth
Key Trends and Developments
Political and Economic Changes Boost Kenya's Performance
Urbanisation Helps Drive Sales of Consumer Health
Rising Health Awareness Boosts Growth
Self-medication Grows With Increased Awareness and Availability
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  Table 9 Life Expectancy at Birth 2006-2011
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2006-2011
  Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
  Table 12 Consumer Health Company Shares 2007-2011
  Table 13 Consumer Health Brand Shares 2008-2011
  Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
  Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
De-listing Or De-reimbursement
Advertising
Packaging
Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
Generics
Definitions
Sources
  Summary 5 Research Sources